These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1160 related items for PubMed ID: 17085007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S, Schwartz GF, Komarnicky L, Garcia-Young JA.
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast.
    Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnbull LW, Fox JN.
    Eur J Surg Oncol; 2001 Nov; 27(7):617-20. PubMed ID: 11669587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of neoadjuvant CMF to avoid mastectomy.
    George ML, Hale PC, Gumpert JR, Hogbin BM, Deutsch GP, Yelland A.
    Eur J Surg Oncol; 1999 Feb; 25(1):50-3. PubMed ID: 10188855
    [Abstract] [Full Text] [Related]

  • 11. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [Abstract] [Full Text] [Related]

  • 12. Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?
    Ring A, Webb A, Ashley S, Allum WH, Ebbs S, Gui G, Sacks NP, Walsh G, Smith IE.
    J Clin Oncol; 2003 Dec 15; 21(24):4540-5. PubMed ID: 14673041
    [Abstract] [Full Text] [Related]

  • 13. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML, Makris A, Taylor NJ, Harrison M, Richman PI, Burcombe RJ, Stirling JJ, d'Arcy JA, Collins DJ, Pittam MR, Ravichandran D, Padhani AR.
    Clin Cancer Res; 2008 Oct 15; 14(20):6580-9. PubMed ID: 18927299
    [Abstract] [Full Text] [Related]

  • 14. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP, Wu MT, Chang HT, Lo YS, Pan HB, Degani H, Furman-Haran E.
    Acad Radiol; 2007 May 15; 14(5):561-73. PubMed ID: 17434070
    [Abstract] [Full Text] [Related]

  • 15. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M, Komoike Y, Motomura K, Koyama H, Inaji H.
    Breast J; 2010 May 15; 16(1):9-13. PubMed ID: 19929889
    [Abstract] [Full Text] [Related]

  • 16. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW.
    Breast Cancer Res Treat; 2005 May 15; 91(1):1-10. PubMed ID: 15868426
    [Abstract] [Full Text] [Related]

  • 17. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.
    J Natl Cancer Inst; 2005 Jan 19; 97(2):116-26. PubMed ID: 15657341
    [Abstract] [Full Text] [Related]

  • 18. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ, Fourquet A, Vicini FA, Haffty B, Taylor M, McCormick B, McNeese M, Pierce LJ, Landmann C, Olivotto IA, Borger J, de La Rochefordiere A, Schultz DJ.
    Cancer; 2001 Mar 15; 91(6):1090-7. PubMed ID: 11267953
    [Abstract] [Full Text] [Related]

  • 19. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, Butler JA.
    Arch Surg; 2007 Sep 15; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [Abstract] [Full Text] [Related]

  • 20. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
    Straver ME, van Adrichem JC, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Gilhuijs KG, Oldenburg HS, Wesseling J, Russell NS, Antonini N, Vrancken Peeters MT.
    Ned Tijdschr Geneeskd; 2008 Nov 15; 152(46):2519-25. PubMed ID: 19055260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.